Basic information
- Name:
Pantoprazole sodium
- CAS No.:
138786-67-1
- Molecular Structure:
- Formula:
- C16H14F2N3NaO4S
- Molecular Weight:
- 405.35
- Deleted CAS:
- 226904-33-2
- Synonyms:
- 1H-Benzimidazole,5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodiumsalt (9CI);5-Difluoromethoxy-2-[[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl]-1H-benzimidazolesodium salt;Controloc;Pantecta;Pantoloc;Pantoprazolesodium salt;Protonix;Zurcal;1H-Benzimidazole,6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodiumsalt (1:1);
- Melting Point:
- 199-202 °C
- Boiling Point:
- 586.9 °C at 760 mmHg
- Flash Point:
- 308.7 °C
- Appearance:
- white to off-white solid
- Hazard Symbols:
Xn- Risk Codes:
- 20/21/22-37/38-41-48
- Safety Description:
- 22-26-36/37/39-45 Details
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Chemistry
.jpg)
IUPAC Name: Sodium 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1,2-dihydrobenzimidazol-3-ide
Molecular Formula: C16H14F2N3NaO4S
Molecular Weight: 405.35 g/mol
SMILES: [Na+].FC(F)Oc1ccc2[n-]c(nc2c1)S(=O)Cc3nccc(OC)c3OC
InChI: InChI=1/C16H14F2N3O4S.Na/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16;/h3-7,15H,8H2,1-2H3;/q-1;+1
Classification Code: Drug / Therapeutic Agent
Product Categories: Active Pharmaceutical Ingredients; Antibiotic Explorer; Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals; Pantoprazole
Flash Point: 308.7 °C
Enthalpy of Vaporization: 87.64 kJ/mol
Boiling Point: 586.9 °C at 760 mmHg
Melting Point: 199-202 °C
Vapour Pressure of Pantoprazole sodium (CAS NO.138786-67-1): 9.37E-14 mmHg at 25 °C
Uses
Pantoprazole sodium (CAS NO.138786-67-1) is used as an antiulcerative.
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intravenous | 395mg/kg (395mg/kg) | Drugs of the Future. Vol. 15, Pg. 801, 1990. | |
| mouse | LD50 | oral | > 1gm/kg (1000mg/kg) | Drugs of the Future. Vol. 15, Pg. 801, 1990. | |
| rat | LD50 | intravenous | 256mg/kg (256mg/kg) | Drugs of the Future. Vol. 15, Pg. 801, 1990. | |
| rat | LD50 | oral | 747mg/kg (747mg/kg) | Drugs of the Future. Vol. 15, Pg. 801, 1990. |
Safety Profile
Hazard Codes: 
Xn
Risk Statements: 20/21/22-37/38-41-48
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed.
R37/38:Irritating to respiratory system and skin.
R41:Risk of serious damage to the eyes.
R48:Danger of serious damage to health by prolonged exposure.
Safety Statements of Pantoprazole sodium (CAS NO.138786-67-1): 22-26-36/37/39-45
S22:Do not breathe dust.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
Specification
Pantoprazole sodium (CAS NO.138786-67-1), its Synonyms are 5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole sodium ; Controloc ; Pantecta ; Pantoloc ; Pantoprazole ; Protonix IV ; Protonix delayed-release ; Zurcal ; 1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-, sodiums salt . It is white to off-white solid.